Pictet Asset Management (UK)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pictet Asset Management (UK)’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-53,042	Closed	-$256K	–	877
2016 Q4	$256K	Sell	53,042 -192,756	-78%	-$5.72M	﹤0.01%	835
2016 Q3	$11.3M	Sell	245,798 -48,672	-17%	-$2.74M	0.04%	408
2016 Q2	$15.8M	Buy	294,470 +266,270	+944%	+$13.2M	0.06%	340
2016 Q1	$1.27M	Hold	28,200	–	–	0.01%	739
2015 Q4	$2.21M	Sell	28,200 -33,400	-54%	-$1.93M	0.01%	707
2015 Q3	$2.5M	Sell	61,600 -43,800	-42%	-$2.32M	0.01%	691
2015 Q2	$7.13M	Buy	+105,400	New	+$5.24M	0.03%	496

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pictet Asset Management (UK)'s ISEE Position: Q1 2017 in Review

Pictet Asset Management (UK) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2017, closing a stake of 53,042 shares — an estimated $256K sold.

Pictet Asset Management (UK) first reported a position in ISEE in Q2 2015 and held it in 7 quarters. The position peaked at $15.8M in Q2 2016. 100 funds tracked by Wall St. Rank hold ISEE as of Q1 2017.

Pictet Asset Management (UK) reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Pictet Asset Management (UK) sold 53,042 IVERIC bio, Inc. Common Stock shares in Q1 2017, an estimated $256K.
Pictet Asset Management (UK) first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
Pictet Asset Management (UK)'s IVERIC bio, Inc. Common Stock position peaked at $15.8M in Q2 2016.
100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2017, filed 4 May 2017.